Betahistine/Reboxetine
倍他司汀/瑞波西汀
Report date: 2022/01/14 13:23:58
Base Information
Drug NameBetahistine/Reboxetine
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Betahistine HydrochlorideReboxetine Mesilate
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTel Aviv University Trust
China Registration ClassN/A
Develop Information
Active CompaniesTel Aviv University Trust
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A